Alexza Pharmaceuticals Inc. 4
4 · Alexza Pharmaceuticals Inc. · Filed Jun 21, 2016
Insider Transaction Report
Form 4
TURNER JOSEPH L
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2016-06-21−2,500→ 0 totalExercise: $28.00From: 2010-08-21Exp: 2020-07-20→ Common Stock (2,500 underlying) - Disposition from Tender
Common Stock
2016-06-21−1,050→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2016-06-21−12,500→ 0 totalExercise: $1.28From: 2016-06-03Exp: 2025-06-02→ Common Stock (12,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2016-06-21−11,606→ 0 totalExercise: $4.68From: 2013-06-21Exp: 2023-05-20→ Common Stock (11,606 underlying) - Disposition to Issuer
Stock Option (right to buy)
2016-06-21−3,991→ 0 totalExercise: $3.50From: 2012-07-06Exp: 2022-06-06→ Common Stock (3,991 underlying) - Disposition to Issuer
Stock Option (right to buy)
2016-06-21−3,125→ 0 totalExercise: $15.30From: 2011-08-28Exp: 2021-07-28→ Common Stock (3,125 underlying)
Footnotes (2)
- [F1]Per the terms of the Agreement and Plan of Merger, dated 5/9/16, among the Issuer, Grupo Ferrer Internactional, S.A. and Ferrer Pharma Inc. (the "Agreement) and the Offer (as defined in the Agreement), each share of the Issuer's common stock was tendered for $0.90 per share in cash, without interest and less any required withholding taxes, plus one contractual contingent value right per share ("CVR") (as defined in the Agreement).
- [F2]Disposed of per Section 3.4(a) of the Agreement, whereby each option that was outstanding immediately prior to the Offer Closing (as defined in the Agreement) was cancelled without consideration.